跳至主要内容
临床试验/NCT03936647
NCT03936647招募中不适用

The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices

Centre hospitalier de l'Université de Montréal (CHUM)6 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年7月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
6
主要终点
Number of patients with a modified Rankin Score (mRS) below or equal to 2

研究概览

简要总结

Intracranial bifurcation aneurysms are commonly repaired with surgical and with endovascular techniques. Wide-necked bifurcation aneurysms (WNBA) are a difficult subset of aneurysms to successfully repair endovascularly, and a number of treatment adjuncts have been designed. One particularly promising innovation is the WEB (Woven EndoBridge), which permits placement of an intra-saccular flow diverting mesh across the aneurysm neck, but which does not require anti-platelet agent therapy. Currently, which treatment option leads to the best outcome for patients with WNBA remains unknown. There is a need to offer treatment with the WEB within the context of a randomized care trial, to patients currently presenting with aneurysms thought to be suitable for the WEB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient with an intracranial aneurysm in whom WEB is considered an appropriate therapeutic option by the participating clinician
  • aneurysm of maximum diameter of 4-11 mm
  • may include (but are not restricted to) saccular bifurcation aneurysms of the middle cerebral artery, basilar bifurcation, carotid terminus, or anterior communicating artery aneurysms
  • Recurring, persistent aneurysm after previous treatment can be included so long as the treating physician judges the aneurysm morphology to be appropriate.
  • Ruptured aneurysms with WFNS ≤ 3

排除标准

  • Absolute contraindication to surgery, endovascular treatment or anesthesia
  • Patients unable to give informed consent
  • diameter of the aneurysm ≤ 4 mm but ≥ 11 mm
  • Ruptured aneurysms with WFNS 4 or 5

结局指标

主要结局

Number of patients with a modified Rankin Score (mRS) below or equal to 2

时间窗: 1 year from procedure

mRS ≤2 from evaluation (questionnaire) at follow-up visits throughout study. Grading score is to be assessed as such: Grade 0 No symptoms at all. Grade 1 No significant disability despite symptoms; able to carry out all usual duties and activities Grade 2 Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance Grade 3 Moderate disability; requiring some help, but able to walk without assistance Grade 4 Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance Grade 5 Severe disability; bedridden, incontinent and requiring constant nursing care and attention Grade 6 Dead

Number of participants with imaging showing that index aneurysm has reached complete or near occlusion

时间窗: 1 year from procedure

complete or near complete occlusion of the aneurysm

次要结局

  • Number of aneurysm re-occurrences, (re-)rupture, or incomplete occlusion based on angiographic imaging(12 +/- 2 months)
  • Hospitalization time(up to first post-procedure visit (around 1 month))
  • Number of peri-operative complications(≥5 days)
  • Number of participants with an interim modified Rankin Scale (mRS) below or equal to 2(within 1 week post-procedure, 1-3 months, and 12 months post-treatment)
  • Number of successful deployment of WEB device, coils or successful microsurgical, clipping, along with judgement of patency of parent arteries using imaging (depending on treatment received)(within 1 hour from procedure)
  • Number of incidences of successful or unsuccesful patency of parent arteries using imaging(within 1 hour from procedure)
  • Incidence of discharge destination by type(up to first post-procedure visit (around 1 month))
  • Number of index aneurysms necessitating or having received retreatment due to re-occurence(Within 12 +/- 2 months)
  • Number of participants with stroke, neurological symptom or sign(within 12 +/- 2 months)

研究者

发起方
Centre hospitalier de l'Université de Montréal (CHUM)
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

The RISE Trial: A Randomized Trial on Intra-Saccular... | 临床试验